Hepatic expression of sodium-glucose cotransporter 2 (sglt2) in patients with chronic liver disease

HIGHLIGHTS

  • who: Dan Nakano from the Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Asahiu2011machi Kurume, Kurume, u20110011, Japan have published the article: Hepatic expression of sodium-glucose cotransporter 2 (SGLT2) in patients with chronic liver disease, in the Journal: (JOURNAL)
  • what: The authors investigate the hepatic expression of SGLT2 and its related factors in patients with chronic liver disease. The authors demonstrated that the expression of SGLT2 was observed in not only in the kidney, but also in the liver, heart, spleen, and brain.
  • how: The mean intensity of the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?